Phoslock Reports Sales Recovery, Factory Restart, and Legal Challenges in 2026

Sales Recovery and Growth Outlook

Phoslock Environmental Technologies (ASX:PET) clawed back from a depressed 2024 to achieve a substantial sales rebound in 2025, returning volumes to more typical levels. The company anticipates further growth in 2026 and 2027, contingent on customer demand, project timing, and broader market conditions. Several large European lake restoration projects remain in active development and could significantly boost sales if they convert into commercial orders, although no guarantees exist. This cautious optimism is underpinned by a generally positive water treatment industry backdrop and ongoing company initiatives.

Resumption of China Production and Cost Implications

A pivotal event in early 2026 was the reopening of Phoslock’s Changxing factory in China after a five-year shutdown. This restart was necessary to replenish depleted inventories and support expected customer demand over the year. However, it also introduced new cash production costs that had been absent during the hiatus. The factory’s operational resumption follows refurbishment and a ramp-up in output, marking a significant shift from previous years when production costs were effectively zero. The company’s decision to restart manufacturing aligns with improved sales volumes and ambitions for growth, as detailed in its recent quarterly updates including the production ramping after factory reopening and manufacturing restart at Changxing.

Progress in Water Treatment Trials and R&D

Phoslock is actively trialling its products in several European wastewater treatment facilities, with encouraging early results. While the company is optimistic these trials will translate into increased sales volumes, the timeline remains uncertain due to slow adoption processes within large wastewater companies. Parallel to this, Phoslock’s R&D efforts are advancing towards a new product variant boasting double the phosphorus-binding capacity of its original lanthanum-modified bentonite (LMB) formula. This innovation could enhance the company’s competitive edge if successfully commercialised, building on the positive momentum seen in recent quarters.

Legal Challenges and Financial Uncertainty

Despite operational improvements, Phoslock continues to grapple with a shareholder class action initiated by Banton Group concerning alleged continuous disclosure breaches related to irregularities in China between 2018 and 2020. The litigation imposes significant uncertainty, not only due to potential financial costs but also because the company must cover legal expenses for former officers under indemnity agreements. This ongoing legal saga tempers the otherwise improving business fundamentals and leaves the outlook clouded until resolved. The company is actively engaging with legal counsel and insurers to manage the situation, which remains a key risk factor for investors.